Nepal DDA Medical Device Registration: Health Technology Product Directive 2074 Guide

Quick answer

Nepal regulates Health Technology Products and Equipment (HTPE) under the Directive on Health Technology Product and Equipment, 2074 (2017) issued by the Government of Nepal and administered by the Department of Drug Administration (DDA). Before any HTPE is sold or distributed inside Nepal, the producer or importer must submit a Schedule-6 application to DDA under Section 4. DDA then inquires whether the product meets the national standard determined under Section 8; if conformity is confirmed, DDA registers the product and issues a Schedule-7 registration certificate. Importers also need a Section 3 import recommendation letter (Schedule-3 application, Schedule-5 letter) before bringing HTPE into the country. Certificates are valid for one year and must be renewed one month before expiry under Section 6.

Who this applies to

This guide applies to:

• Foreign manufacturers exporting medical devices, diagnostic equipment, or other HTPE to Nepal
• Nepalese importers and local producers placing HTPE on the market
• Distributors and retailers opening sales centres, firms, or shops for HTPE (Section 5)
• Regulatory affairs teams mapping India CDSCO, Sri Lanka NMRA, or ASEAN pathways to Nepal's HTPE framework

Scope covers all products listed in Schedule-1 of the directive—not only classical medical devices but also laboratory equipment, home-use diagnostics, certain supplements, and related consumables. If your product appears in Schedule-1, assume DDA oversight unless DDA publishes a specific exemption.

Regulatory framework: Directive 2074 and DDA

The Health Technology Product and Equipment Directive, 2074 (2017) (commonly called Directive 2074) was approved by Nepal's Council of Ministers and is published on the government CDN and on dda.gov.np under Directives and Guidance. DDA, under the Ministry of Health and Population, is the Department referenced throughout the directive.

The directive operates alongside:

Operating HTPE without the required certificates or recommendation letters triggers action under existing laws (Section 17). Treat unregistered supply as a hard stop—not a post-market cleanup task.

What is HTPE? Schedule-1 product scope

Section 2(D) defines Health Technology Product or Equipment as products listed in Schedule-1. Schedule-1 is broad by design. Key categories include:

Schedule-1 also lists nutritional supplements not regulated as drugs or food, certain OTC items outside DDA drug oversight, and cosmetic items with potential health hazards. Confirm your exact product against the published Schedule-1 text on dda.gov.np before assuming "device-only" scope.

Section 4: product registration before sales and distribution

Section 4 is the core market-access gate for individual HTPE. The three-step logic is explicit:

1. Application (Sub-section 1): Before sales and distribution inside Nepal, a person who produces or imports the HTPE must submit an application to DDA in the format of Schedule-6.
2. National standard inquiry (Sub-section 2): On receipt, DDA inquires whether the HTPE meets the national standard according to Section 8.
3. Registration and certificate (Sub-section 3): If the product meets the national standard, DDA registers it and issues a registration certificate per Schedule-7 to the applicant.

Section 4 does not replace import controls—it runs in parallel with Section 3 for importers. You need both the import recommendation letter (to import) and the Schedule-7 certificate (to sell and distribute).

Schedule-6 application contents

Schedule-6 is titled Application Format for the Certificate for the Sales and Distribution of the Health Technology Product or Equipment. It is addressed to the Director General, Department of Drug Administration and requires:

• Applicant signature, name, address, and date
• A tabular detail of HTPE wanting sale and distribution, including serial number, name, form/type, and remarks columns

Prepare supporting technical evidence—specifications, manufacturing site details, quality certificates, and conformity documentation—so DDA can complete the Section 8 inquiry even though Schedule-6 itself is a short form.

Schedule-7 registration certificate

Schedule-7 is the Certificate for the Sales and Distribution of the Health Technology Product or Equipment. It states that DDA issued the registration certificate under Section 4(3) after inquiry on the Schedule-6 application, and lists the registered product details (name, form/type, remarks) with official stamp and signing officer.

Keep Schedule-7 certificates available for customs, distributor audits, and DDA inspections. Product labels and import documentation should align with registered name and form/type exactly.

Section 8: national standard determination

Before DDA registers under Section 4, it must confirm conformity with the national standard determined under Section 8:

Section 9 reinforces that any HTPE produced, imported, sold, or distributed in Nepal must comply with the Section 8 national standard.

Quality testing chain (Sections 10–11)

Section 10 assigns testing responsibility in a defined cascade:

1. National Bureau of Standards & Metrology (Ministry of Industry) tests quality against the national standard where capable
2. If not, National Medicine Laboratory (under DDA) or National Public Health Laboratory
3. If still not possible, a laboratory of international standard designated by DDA on recommendation of the Drugs Advisory Council or Committee

Section 11 prohibits producing or importing HTPE that does not meet the national standard, and explicitly bans import of products already used once, or that are old, repaired, or rebuilt.

Section 15 states that testing costs are borne by the producer or importer. Budget for laboratory fees in your Nepal access plan.

Import gate: Section 3 recommendation letter

Importers must secure a Recommendation Letter under Section 3 before export/import activities:

Schedule-3 requires product detail: name, form/type, manufacturing country, exporting/importing country, quantity, and remarks.

Section 12 allows export/import through an authorized agent registered with DDA. Section 12 Explanation defines authorized agent as an individual registered by the recommendation-letter holder. Foreign manufacturers typically appoint a local agent or importer to manage DDA correspondence, fee payment, and renewal applications—align your commercial agreement with who holds Section 3 and Section 4 certificates.

Three-gate market access model

Gate 1 — Import (Section 3)
  Schedule-3 application → DDA inquiry → Schedule-5 Recommendation Letter

Gate 2 — Product registration (Section 4)
  Schedule-6 application → Section 8 standard inquiry → Schedule-7 Certificate

Gate 3 — Sales outlet (Section 5, if retailing/wholesaling)
  Schedule-8 application → Schedule-9 outlet certificate

Gate 1 and Gate 2 apply to every importer. Gate 3 applies when you operate a sales centre, firm, or shop—not merely when you supply through hospital tenders.

Validity, renewal, and fees

Section 6 governs all recommendation letters and certificates:

DDA may collect service fees under Section 14 per existing law. Fee amounts change with government notices—verify current schedules on dda.gov.np Notices before budgeting; do not rely...